Daniel Raynor, Director at ANI PHARMACEUTICALS INC (ANIP), sold 200,000 shares at $63.00 ($12.6M) on 2015-03-12, disclosed to the SEC on 2015-03-16.
Open-market sale of $12.6M ANIP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ANIP | SELL | 2014-03-18 | $716K | — | Filing → |
| ANIP | SELL | 2014-03-18 | $418K | — | Filing → |
| ANIP | SELL | 2014-03-14 | $715K | — | Filing → |